Notably, resveratrol intervention in a PTEN knockout mouse model of PCa suppressed mTORC1 activity and upregulated SIRT1, highlighting the therapeutic potential of targeting this axis. The gene discussed is SIRT1; the disease is posterior cortical atrophy.